Topics
- Overcome Business Concerns about Monetizing "Big Data" & Leveraging Informatics to Deliver Effective Targeting/Engagement
- Understand how data, measurements and informatics can be utilized to demonstrate ROI across channels
- Realize the promise of data materialized for more effective and efficient targeting
- Innovation around patients: taking data and turning it into insights: predictive modeling, profile-targeted TV buys, re-targeting
- Social Media, Innovating and Risk avoidance - Taking a `Can Do` Approach
- Decipher new FDA guidance, and how MLR/compliance/legal/marketing can work better with regulators and each other
- Make progress in gaining approval for moderated commenting in social media
- Review out of industry best practice case studies that can be leveraged as part of a `can do in pharma` approach
- Gain practical insights and lessons about fair balance and risk information and
- Analyze What Digital Innovation Looks like in Pharma today
- Wearable technology and quantified self towards holistic healthcare outcome models
- Adjunctive technologies Integration into the Pharma Model: Mobile, Digital, Device etc
- Assess how new technologies are changing the way we can deliver our messages
- Consumerization of healthcare - novel customer interfaces
- Analyze `connected digital health` and how consumers, their phone and connected devices, will change the way you do business
- The commoditization of digital; reducing cost base whilst also fostering innovation
- Actually Put Your Customer in the Center of Your Planning through Optimized Customer Centricity
- Customer experience management
- Customer-centered brand management
- Content marketing
- Customer interaction management
- Multi-channel integrated content strategy
- Change Management Roadmaps , Evolving the Pharma Business Model & Providing Value Beyond the Pill
- Introduce digital in the value proposal of pharma companies, and develop value added services to provide true value beyond the pill
- Develop robust business models that foster quicker collaboration between divisions, allows for decision making processes to be made at lower levels of seniority and increases accountability in a cost effective manner
- Move from digital to a service: understand the stakeholders to focus on. From HCPs to payor and patients - who will be willing to pay?
Who should Attend
Attendees from the pharma and biotech industries and also from medical device, government, academic institutes and industry service providers.
